TTNP

Titan Pharmaceuticals

Delisted

TTNP was delisted on the 1st of October, 2025.

19 hedge funds and large institutions have $374K invested in Titan Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
7
Reduced
1
Closed
3
Calls
$6K
Puts
Net Calls
+$6K
Net Calls Change
-$7K
Name Holding Trade Value Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$135K +$115K +10,210 +559%
Vanguard Group
2
Vanguard Group
Pennsylvania
$42K -$73.8K -6,576 -64%
Millennium Management
3
Millennium Management
New York
$35K +$29.3K +2,643 +516%
VF
4
Virtu Financial
New York
$35K +$35K +3,117 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$34K +$5.07K +465 +18%
Group One Trading
6
Group One Trading
Illinois
$33K +$333 +30 +1%
HF
7
HRT Financial
New York
$29K +$29K +2,605 New
UBS Group
8
UBS Group
Switzerland
$15K +$11K +991 +278%
E
9
Ergoteles
New York
$11K +$11K +949 New
IA
10
IFP Advisors
Florida
$3K
LFA
11
Level Financial Advisors
New York
$1K
Citigroup
12
Citigroup
New York
$1K +$1K +88 New
APA
13
American Portfolios Advisors
New York
$13
AC
14
Armistice Capital
New York
-$826K -43,176 Closed
Barclays
15
Barclays
United Kingdom
-$48K -2,503 Closed
TRCT
16
Tower Research Capital (TRC)
New York
-$10K -502 Closed